Founded in 2015 and headquartered in Palo Alto, California, I Peace, Inc. operates as a cell and gene therapy contract development and manufacturing organisation (CDMO). The company focuses on manufacturing clinical-grade induced pluripotent stem cells (iPSCs) and differentiated cell products under cGMP standards. Its proprietary automation platform enables parallel production of multiple donor-derived iPSC lines in a single facility, significantly reducing cost and production time for pharmaceutical, biotech, academic, and individual clients. I Peace holds FDA and Japanese regulatory approvals, including GMP facility registration and Drug Master File listings, as well as ISO 17025 accreditation for its analytical labs . The company aims to democratise access to iPSC technology, providing both off-the-shelf and personalised cell products to support research, drug discovery, cell therapy development, and personal

Key Products & Services

GMP-grade iPSC/CDMO services: Production of clinical-grade iPSCs and differentiated cell lines for therapeutic and research use.

Research-grade iPSC products: Supply of non-clinical cell lines for drug discovery and basic research

Personal iPSC banking (“My Peace”): Long-term storage of individual’s iPSCs for potential future therapeutic use.

Off-the-shelf GMP iPSC lines: Diverse HLA-homozygous and low-immunoreaction lines, including type O female and HLA-A/C/DP homozygous lines covering ~36% of the US population.

Analytical & QC services: ISO 17025-accredited assays for flow cytometry, immunofluorescence, cell viability, and viral vector detection.

I Peace combines deep technological innovation with robust regulatory credentials and flexible service offerings. By making high-quality, GMP-grade iPSC lines widely accessible—whether off-the-shelf or personalised—the company supports faster drug discovery, scalable cell therapy development, and individual readiness for future regenerative interventions. With global ambitions anchored by regulatory compliance and automated manufacturing, I Peace is well-positioned to shape the future of cell and gene therapy.